Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.684
+0.010 (1.50%)
Apr 29, 2026, 10:08 AM EDT - Market open
Pasithea Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Revenue | - | - | - | - | 0.02 | Upgrade
|
| Cost of Revenue | - | - | - | - | 0.02 | Upgrade
|
| Gross Profit | - | - | - | - | -0 | Upgrade
|
| Selling, General & Admin | 8.71 | 7.05 | 7.88 | 9.92 | 4.51 | Upgrade
|
| Research & Development | 7.98 | 7.2 | 8.1 | 2.67 | - | Upgrade
|
| Operating Expenses | 16.69 | 14.25 | 15.98 | 12.59 | 4.51 | Upgrade
|
| Operating Income | -16.69 | -14.25 | -15.98 | -12.59 | -4.51 | Upgrade
|
| Interest Expense | - | - | - | - | -0 | Upgrade
|
| Interest & Investment Income | 0.33 | 0.42 | 0.42 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.02 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | -0.08 | 0.06 | 1.85 | 2.33 | Upgrade
|
| EBT Excluding Unusual Items | -16.26 | -13.9 | -15.51 | -10.74 | -2.17 | Upgrade
|
| Impairment of Goodwill | -1.26 | - | - | - | - | Upgrade
|
| Asset Writedown | -2.9 | - | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | -1 | - | Upgrade
|
| Other Unusual Items | - | - | - | 0.01 | - | Upgrade
|
| Pretax Income | -20.43 | -13.9 | -15.51 | -11.73 | -2.17 | Upgrade
|
| Earnings From Continuing Operations | -20.43 | -13.9 | -15.51 | -11.73 | -2.17 | Upgrade
|
| Earnings From Discontinued Operations | - | - | -0.45 | -2.21 | - | Upgrade
|
| Net Income | -20.43 | -13.9 | -15.96 | -13.94 | -2.17 | Upgrade
|
| Net Income to Common | -20.43 | -13.9 | -15.96 | -13.94 | -2.17 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 541.47% | -10.64% | -2.83% | 142.65% | 41.29% | Upgrade
|
| EPS (Basic) | -2.91 | -12.69 | -13.01 | -11.04 | -4.18 | Upgrade
|
| EPS (Diluted) | -2.91 | -12.69 | -13.01 | -11.04 | -4.18 | Upgrade
|
| Free Cash Flow | -15.21 | -13.92 | -13.46 | -13.8 | -3.2 | Upgrade
|
| Free Cash Flow Per Share | -2.16 | -12.70 | -10.97 | -10.93 | -6.14 | Upgrade
|
| Gross Margin | - | - | - | - | -14.69% | Upgrade
|
| Operating Margin | - | - | - | - | -29925.73% | Upgrade
|
| Profit Margin | - | - | - | - | -14430.49% | Upgrade
|
| Free Cash Flow Margin | - | - | - | - | -21216.05% | Upgrade
|
| EBITDA | -16.03 | -13.6 | -15.33 | -12.58 | -4.51 | Upgrade
|
| D&A For EBITDA | 0.66 | 0.65 | 0.65 | 0.01 | 0 | Upgrade
|
| EBIT | -16.69 | -14.25 | -15.98 | -12.59 | -4.51 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.